1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
- The serotonergic system in L-DOPA-induced dyskinesia : pre-clinical evidence and clinical perspective
- 2017
- BDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to L-DOPA-induced dyskinesia in 6-OHDA-lesioned rats
- 2013
- mTOR Inhibition Alleviates L-DOPA-Induced Dyskinesia in Parkinsonian Rats
- Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia
- Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia
- 2010
- Neural grafting in Parkinson's disease: unraveling the mechanisms underlying graft-induced dyskinesia
- 2008
- Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia.
- 2007
- Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats.
- 2006
- Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia.
- 2005
- Reversal of dyskinesias in an animal model of Parkinson's disease by continuous L-DOPA delivery using rAAV vectors.